Yoko Wada

2.6k total citations
78 papers, 1.2k citations indexed

About

Yoko Wada is a scholar working on Rheumatology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yoko Wada has authored 78 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Rheumatology, 24 papers in Molecular Biology and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yoko Wada's work include Systemic Lupus Erythematosus Research (18 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (16 papers) and Renal Diseases and Glomerulopathies (11 papers). Yoko Wada is often cited by papers focused on Systemic Lupus Erythematosus Research (18 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (16 papers) and Renal Diseases and Glomerulopathies (11 papers). Yoko Wada collaborates with scholars based in Japan, Australia and United States. Yoko Wada's co-authors include Ichiei Narita, Masaaki Nakano, Takeshi Kuroda, Fumitake Gejyo, Hiroe Sato, Shuichi Murakami, Naohito Tanabe, Takako Saeki, Daisuke Kobayashi and Satoshi Ito and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes and Kidney International.

In The Last Decade

Yoko Wada

74 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoko Wada Japan 22 418 378 361 298 189 78 1.2k
Masaaki Nakano Japan 22 419 1.0× 184 0.5× 339 0.9× 174 0.6× 204 1.1× 80 1.0k
Élisabeth Palazzo France 21 939 2.2× 348 0.9× 161 0.4× 162 0.5× 216 1.1× 51 1.4k
Roland Kocijan Austria 27 630 1.5× 520 1.4× 525 1.5× 138 0.5× 132 0.7× 111 1.9k
Marcos A. González‐López Spain 18 351 0.8× 275 0.7× 132 0.4× 268 0.9× 95 0.5× 69 1.1k
Andrew D. Frutkin United States 14 111 0.3× 382 1.0× 307 0.9× 98 0.3× 213 1.1× 18 1.2k
Xiaofeng Zeng China 26 1.2k 2.9× 396 1.0× 259 0.7× 351 1.2× 104 0.6× 134 2.0k
Dimitrios Daoussis Greece 26 872 2.1× 202 0.5× 423 1.2× 541 1.8× 123 0.7× 93 2.4k
Hitoshi Goto Japan 14 355 0.8× 77 0.2× 152 0.4× 160 0.5× 172 0.9× 34 951
R. Woodward United States 12 319 0.8× 717 1.9× 312 0.9× 95 0.3× 56 0.3× 35 1.5k
Joanne Joseph Australia 24 152 0.4× 526 1.4× 359 1.0× 119 0.4× 46 0.2× 63 1.8k

Countries citing papers authored by Yoko Wada

Since Specialization
Citations

This map shows the geographic impact of Yoko Wada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoko Wada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoko Wada more than expected).

Fields of papers citing papers by Yoko Wada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoko Wada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoko Wada. The network helps show where Yoko Wada may publish in the future.

Co-authorship network of co-authors of Yoko Wada

This figure shows the co-authorship network connecting the top 25 collaborators of Yoko Wada. A scholar is included among the top collaborators of Yoko Wada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoko Wada. Yoko Wada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sato, Hiroe, Naoki Kondo, Daisuke Kobayashi, et al.. (2019). High bisphosphonate treatment rates and the prevalence of atypical femoral fractures in patients with systematic lupus erythematosus: a single-center retrospective study performed in Japan. Rheumatology International. 39(10). 1803–1810. 7 indexed citations
2.
Kuroda, Takeshi, Naohito Tanabe, Hiroe Sato, et al.. (2018). Association between Elevated Mean Corpuscular Volume and C-reactive protein in Patients with Rheumatoid Arthritis. 1(5). 1 indexed citations
3.
Wada, Yoko, Hisashi Hasegawa, Takako Saeki, et al.. (2017). Long-term prognosis and factors associated with damage accrual in Japanese patients with systemic lupus erythematosus. Clinical and Experimental Nephrology. 22(3). 597–602. 9 indexed citations
4.
Takai, Chinatsu, Yoko Wada, & Ichiei Narita. (2015). Atypical skin involvement in Erdheim–Chester disease: Fig. 1. Lara D. Veeken. 54(12). kev317–kev317. 1 indexed citations
5.
Toyoshima, Yasuko, Yoko Wada, Tetsuya Takahashi, et al.. (2015). A Fulminant Case of Granulomatosis with Polyangiitis with Meningeal and Parenchymal Involvement. Case Reports in Neurology. 7(1). 101–104. 4 indexed citations
6.
Kuroda, Takeshi, Hiroe Sato, Takeshi Nakatsue, et al.. (2014). Effects of a biologic agent in a patient with rheumatoid arthritis after treatment for methotrexate-associated B-cell lymphoma: a case report. BMC Research Notes. 7(1). 229–229. 5 indexed citations
7.
Kuroda, Takeshi, Naohito Tanabe, Hiroe Sato, et al.. (2013). Distribution of amyloid deposits in the kidneys of a patient with reactive amyloidosis associated with rheumatoid arthritis. BMC Research Notes. 6(1). 231–231. 2 indexed citations
8.
Iguchi, Akira, Yoko Wada, Daisuke Kobayashi, et al.. (2012). A case of MPO- and PR3-ANCA-positive hypertrophic cranial pachymeningitis with elevated serum IgG4. Modern Rheumatology. 23(1). 151–155. 16 indexed citations
9.
Kuroda, Takeshi, Naohito Tanabe, Daisuke Kobayashi, et al.. (2012). Treatment with Biologic Agents Improves the Prognosis of Patients with Rheumatoid Arthritis and Amyloidosis. The Journal of Rheumatology. 39(7). 1348–1354. 22 indexed citations
10.
Wada, Yoko, Masaru Kojima, Daisuke Kobayashi, et al.. (2012). A case of Epstein–Barr virus-related lymphadenopathy mimicking the clinical features of IgG4-related disease. Modern Rheumatology. 23(3). 597–603. 7 indexed citations
11.
Kuroda, Takeshi, Naohito Tanabe, Daisuke Kobayashi, et al.. (2011). Significant association between renal function and area of amyloid deposition in kidney biopsy specimens in reactive amyloidosis associated with rheumatoid arthritis. Rheumatology International. 32(10). 3155–3162. 21 indexed citations
12.
Kuroda, Takeshi, Naohito Tanabe, Daisuke Kobayashi, et al.. (2010). Programmed initiation of hemodialysis for systemic amyloidosis patients associated with rheumatoid arthritis. Rheumatology International. 31(9). 1177–1182. 4 indexed citations
13.
Wada, Yoko, Takeshi Kuroda, Akira Murasawa, Masaaki Nakano, & Ichiei Narita. (2010). Anti-neutrophil cytoplasmic autoantibodies against bactericidal/permeability-increasing protein in patients with rheumatoid arthritis and their correlation with bronchial involvement. Modern Rheumatology. 20(3). 252–256. 8 indexed citations
14.
Kuroda, Takeshi, Daisuke Kobayashi, Hiroe Sato, et al.. (2010). Mizoribine therapy in a patient with lupus nephritis: the association between mizoribine concentration and peritoneal dialysis. Modern Rheumatology. 20(3). 296–300. 3 indexed citations
15.
Sato, Hiroe, Takashi Miida, Yoko Wada, et al.. (2007). Atherosclerosis is accelerated in patients with long-term well-controlled Systemic Lupus Erythematosus (SLE). Clinica Chimica Acta. 385(1-2). 35–42. 37 indexed citations
16.
Ito, Satoshi, Mamoru Watanabe, Shuichi Nomura, et al.. (2004). Increase in the ratio of matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 in saliva from patients with primary Sjögren's syndrome. Clinica Chimica Acta. 345(1-2). 99–104. 32 indexed citations
17.
Kanazawa, Masato, Yoko Wada, Hisao Tanaka, et al.. (2004). Mixed connective tissue disease associated with antineutrophil cytoplasmic antibodies against proteinase-3 and systemic atherosclerosis: a case report. Clinical Rheumatology. 23(5). 456–459. 8 indexed citations
18.
Wada, Yoko, Tetsuo Morioka, Jian Yao, et al.. (2002). Impairment of vascular regeneration precedes progressive glomerulosclerosis in anti-Thy 1 glomerulonephritis. Kidney International. 61(2). 432–443. 56 indexed citations
19.
Nakazato, Kazuhiko, Toshiyuki Ishibashi, Kenji Nagata, et al.. (2001). Expression of very low density lipoprotein receptor mRNA in circulating human monocytes: its up-regulation by hypoxia. Atherosclerosis. 155(2). 439–444. 21 indexed citations
20.
Wada, Yoko, Yoshimi Homma, Kazuhiko Nakazato, Toshiyuki Ishibashi, & Yukio Maruyama. (2000). Effect of overexpression of very low density lipoprotein receptor on cell growth. Heart and Vessels. 15(2). 74–80. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masaaki Nakano Breakdown of academic impact, for papers by Élisabeth Palazzo Breakdown of academic impact, for papers by Roland Kocijan Breakdown of academic impact, for papers by Marcos A. González‐López Breakdown of academic impact, for papers by Andrew D. Frutkin Breakdown of academic impact, for papers by Xiaofeng Zeng Breakdown of academic impact, for papers by Dimitrios Daoussis Breakdown of academic impact, for papers by Hitoshi Goto Breakdown of academic impact, for papers by R. Woodward Breakdown of academic impact, for papers by Joanne Joseph
Rankless by CCL
2026